Sign in

AVITHRAPID

@avithrapid.bsky.social
34 followers 17 following 144 posts

The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.

PostsRepliesMedia
AVITHRAPID @avithrapid.bsky.social · 05/10/2026
🔬 Thank you for exploring antiviral research with us at European Researchers’ Night 2026! To every visitor who stopped by, asked a question or joined an activity: you made it special. Thanks to our researchers, partners and organisers for making it happen! #AVITHRAPID #ERN2026
010
AVITHRAPID @avithrapid.bsky.social · 02/10/2026
🔬 AVITHRAPID was discussed at #IAAASS26, held on 21–25 September in Sardinia. An interactive Summer School connecting early-career researchers and international experts to explore advanced methods and OMICs approaches for antiviral discovery. sites.unica.it/iaaass/ #AVITHRAPID
000
AVITHRAPID @avithrapid.bsky.social · 22/09/2026
AVITHRAPID will be presented at #BrightNight2026! 🔬 Join us on 25 September at Santa Maria della Scala in Siena for the European Researchers’ Night. #ONEINNOVATION #ONEHEALTH #ONEHUMANITY 👉 bright-night.it/enti...
000
AVITHRAPID @avithrapid.bsky.social · 17/09/2026
🔬 #AVITHRAPID is coming to Rome! Join us on 25 September at INMI Spallanzani for La Notte dei Ricercatori e delle Ricercatrici 🇮🇹 🕕 6 PM–12 AM 🧪 34 interactive labs, games & activities 🎟️ Free admission Discover how research helps us prepare for future viral threats. #ERN2026
010
AVITHRAPID @avithrapid.bsky.social · 15/09/2026
🔬 #AVITHRAPID is coming to Rome! Join us on 25 September at INMI Spallanzani for La Notte dei Ricercatori e delle Ricercatrici 🇮🇹 🕕 6 PM-12 AM 🧪 34 interactive labs, games & activities 🎟️ Free admission Discover more: settimanadellascienz... #ERN2026
settimanadellascienza.inmi.it
La Settimana della Scienza 2026 · IRCCS Spallanzani
20–25 settembre 2026 · Sei giornate di divulgazione, ricerca e incontri all'IRCCS Lazzaro Spallanzani. Ogni passo cambia il futuro.
010
AVITHRAPID @avithrapid.bsky.social · 11/09/2026
www.sharper-night.it... 🔬 Can milk help us develop new antiviral therapies? On 25 September, #AVITHRAPID joins #SHARPER in Perugia 🇮🇹 At the EU Corner, discover how milk-derived extracellular vesicles could become innovative delivery systems for antiviral drugs. #ERN2026 #ResearchersNight
sharper-night.it
EU Corner - SHARPER Night
- EU Corner
010
AVITHRAPID @avithrapid.bsky.social · 09/09/2026
💻🔬 Can a supercomputer help discover new antiviral drugs? On 25 September, #AVITHRAPID joins Noc vědy 2026 at IT4Innovations in Ostrava 🇨🇿 Explore real simulations, become a molecular detective and discover how computation helps accelerate antiviral drug discovery! #ERN2026
000
AVITHRAPID @avithrapid.bsky.social · 25/08/2026
Science is closer than you think. 🔬🌍 On 25 September, the European Researchers’ Night will connect researchers and citizens across Europe. At AVITHRAPID, we celebrate those working together to develop new solutions against emerging viral threats. avithrapid.eu
000
AVITHRAPID @avithrapid.bsky.social · 19/08/2026
The European Researchers' Night is a chance to connect science with society. Join AVITHRAPID to discover how antiviral research is helping build a healthier, more resilient future. avithrapid.eu/europe... #AVITHRAPID #ResearchersNight #ScienceCommunication
000
AVITHRAPID @avithrapid.bsky.social · 12/08/2026
AVITHRAPID has launched its new website! More than a project page, it's now a platform for citizens, researchers and partners, with new learning resources, an Innovation Gateway and collaboration tools. Explore what's new: avithrapid.eu #AVITHRAPID #Science #HorizonEurope
avithrapid.eu
Avithrapid project - AVITHRAPID
The AVITHRAPID consortium “Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases” is part of the Horizon Europe Framework Programme and consists of 18 participants and partners from 8 countries.
040
AVITHRAPID @avithrapid.bsky.social · 07/08/2026
From discovering innovative molecules to validating their activity in efficacy models, the team works to move promising antiviral candidates closer to future clinical development. #DrugDiscovery #Virology #EUResearch
010
AVITHRAPID @avithrapid.bsky.social · 07/08/2026
🔬 Discover the science behind #AVITHRAPID! Prof. Vincenzo Summa from the University of Naples introduces Work Package One, dedicated to identifying new chemical entities with broad-spectrum antiviral potential.
110
AVITHRAPID @avithrapid.bsky.social · 05/08/2026
From analysing Dengue virus sequences to predicting new antiviral molecules against SARS-CoV-2, their work aims to uncover new therapeutic strategies to tackle viral infections.
000
AVITHRAPID @avithrapid.bsky.social · 05/08/2026
Prof. Francesca Ceccherini-Silberstein from the University of Rome Tor Vergata shares how her team is contributing to the project through cutting-edge virological research.
110
AVITHRAPID @avithrapid.bsky.social · 03/08/2026
🎥 Elisabeth Reus from the Swiss Tropical and Public Health Institute explains how AVITHRAPID bridges preclinical research and clinical application, helping advance innovative antiviral therapies and improve preparedness for future infectious disease threats. #AVITHRAPID #SwissTPH #horizoneurope
010
AVITHRAPID @avithrapid.bsky.social · 23/07/2026
Carmine Talarico, Manager at Dompé, introduces himself at the #AVITHRAPID consortium meeting in Cagliari. He's part of WP4, the work package selecting the compound to advance to the project's next phase. The video on YouTube avithrapid's channel! #HorizonEurope #DrugDiscovery #AntiviralResearch
010
AVITHRAPID @avithrapid.bsky.social · 21/07/2026
What should be Europe's top priority for future pandemic preparedness? •Broad-spectrum antivirals • AI • Diagnostics • Collaboration Vote! #AVITHRAPID #Poll
000
AVITHRAPID @avithrapid.bsky.social · 16/07/2026
Prof. Enzo Tramontano from the University of Cagliari shares exciting progress from the project’s research activities. #AVITHRAPID #Virology #Research #Antivirals #Science #HorizonEurope
020
AVITHRAPID @avithrapid.bsky.social · 09/07/2026
Today, we asked AVITHRAPID Coordinator Bjoern W. to share his thoughts on the project's progress following the Work Package presentations. A valuable reflection on our achievements so far and the importance of collaboration in strengthening pandemic preparedness through research and innovation.
040
AVITHRAPID @avithrapid.bsky.social · 08/07/2026
Thanks to Prof.Enzo Tramontano and the University of Cagliari for the warm hospitality. Stay tuned for Day 2! #AVITHRAPID #EUResearch
000
AVITHRAPID @avithrapid.bsky.social · 08/07/2026
🇮🇹 Day 1 of the AVITHRAPID Consortium Meeting in Cagliari! Partners from across Europe shared the latest progress on WP1 & WP2, discussed next milestones, and strengthened collaboration through valuable face-to-face exchanges.
100
AVITHRAPID @avithrapid.bsky.social · 08/07/2026
🇮🇹 Day 1 of the AVITHRAPID Consortium Meeting in Cagliari! Partners from across Europe shared the latest progress on WP1 & WP2, discussed next milestones, and strengthened collaboration through valuable face-to-face exchanges.
100
AVITHRAPID @avithrapid.bsky.social · 03/07/2026
The @helmholtzhzi.bsky.social is part of the AVITHRAPID consortium, bringing expertise in chemical biology and small-molecule drug discovery to accelerate antiviral innovation. Together, we're strengthening Europe's preparedness for future viral threats. #DrugDiscovery #HorizonEurope
010
AVITHRAPID @avithrapid.bsky.social · 23/06/2026
Face-to-face collaboration remains vital to accelerating drug discovery against emerging viral threats. #AVITHRAPID #Cagliari2026 #HorizonEurope #OpenScience
000
AVITHRAPID @avithrapid.bsky.social · 23/06/2026
🔬 AVITHRAPID is heading to Cagliari! This July, our consortium will gather in Sardinia, Italy, for a key project meeting. All 19 partners from across Europe will come together to share the latest research updates and coordinate the next steps for our flexible antiviral response platform. 🌍
100
AVITHRAPID @avithrapid.bsky.social · 19/06/2026
Blending technology and virology is how we build a flexible, rapid-response platform to protect global health. Learn more: avithrapid.eu #AVITHRAPID #ArtificialIntelligence #DrugDiscovery #OpenScience
010
AVITHRAPID @avithrapid.bsky.social · 19/06/2026
By predicting how compounds interact with viral proteins, AI allows our researchers to bypass traditional trial-and-error, fast-tracking the most promising antiviral candidates to physical lab testing in a fraction of the time. 🌍
100
AVITHRAPID @avithrapid.bsky.social · 19/06/2026
🤖 AI is a game-changer for pandemic preparedness. At AVITHRAPID, we leverage advanced computational models and Artificial Intelligence to screen thousands of small molecules in silico. 🔬
130
AVITHRAPID @avithrapid.bsky.social · 12/06/2026
By utilizing prior clinical experience responsibly, we aim to accelerate the pathway to drug discovery and build a flexible platform capable of rapid response to emerging threats. Learn more: avithrapid.eu #AVITHRAPID #Dengue #Chikungunya #PublicHealth
010
AVITHRAPID @avithrapid.bsky.social · 12/06/2026
AVITHRAPID is adopting a pragmatic strategy: leveraging existing antiviral knowledge and clinically advanced approaches to fast-track the evaluation of new therapies. 🦟
100
AVITHRAPID @avithrapid.bsky.social · 12/06/2026
🔬 Major update from AVITHRAPID: We are strengthening our focus on dengue and chikungunya. As these mosquito-borne diseases spread globally, specific treatment options remain limited.
100
AVITHRAPID @avithrapid.bsky.social · 03/06/2026
Subscribe to our newsletter to download our brief report on hantavirus mechanisms and future therapeutic perspectives: avithrapid.eu/avithr... #AVITHRAPID #Hantavirus #OpenScience
avithrapid.eu
AVITHRAPID and Hantaviruses - AVITHRAPID project
Hantaviruses are a group of viruses carried by rodents such as mice and rats and transmitted through their droppings and urine. Hantaviruses are present throughout the world and can be found in parts of Europe, Africa, Asia, and South America. Where present, they can cause a range of diseases, from mild flu-like illness to severe respiratory disease For AVITHRAPID, hantaviruses are strategically relevant not because they represent the single highest-probability pandemic threat, but because they expose many of the core challenges of antiviral preparedness at once. Hantaviruses matter for AVITHRAPID for a number of reasons. Do you want to learn more and access our brief report? Subscribe to the AVITHRAPID newsletter to download the full report.
000
AVITHRAPID @avithrapid.bsky.social · 03/06/2026
🔬 Hantaviruses are present worldwide, causing everything from mild flu-like symptoms to severe respiratory illness. For AVITHRAPID, they are strategically vital because they embody the core challenges of rapid antiviral development. Want to learn more?
100
AVITHRAPID @avithrapid.bsky.social · 28/05/2026
How AI reduces time in drug discovery: By simulating billions of molecular interactions, #AVITHRAPID identifies the most promising candidates faster than ever. Technology meets biology to accelerate pandemic response. 🤖🧪 #AI #Science #HealthTech
010
AVITHRAPID @avithrapid.bsky.social · 22/05/2026
#AVITHRAPID #Biotechnology #Pharmaceuticals #AcademicResearch #Antiviral"
000
AVITHRAPID @avithrapid.bsky.social · 22/05/2026
By merging biotechnology with drug delivery expertise, they are creating a biohybrid EV-liposome platform using milk-derived extracellular vesicles. A vital step forward in translating antiviral molecules into versatile, bioinspired treatments. 🧪🛡️
100
AVITHRAPID @avithrapid.bsky.social · 22/05/2026
The AVITHRAPID consortium continues to expand its technical capabilities with the expertise of the University of Perugia (UniPG). 🧬 The team’s contribution focuses on the development of advanced delivery vehicles for antiviral compounds.
100
AVITHRAPID @avithrapid.bsky.social · 19/05/2026
Innovation needs protection - but also collaboration. At AVITHRAPID, progress happens where knowledge is shared, connected, and applied to real-world antiviral challenges. #AVITHRAPID #Innovation #Science
010
AVITHRAPID @avithrapid.bsky.social · 15/05/2026
The goal of #AVITHRAPID? Preparedness. By developing a pipeline of drugs against diverse virus families now, we are creating a shield for the future. Proactive research is the key to global safety. 🌍🔬 #Preparedness #Antiviral #PublicHealth
000
AVITHRAPID @avithrapid.bsky.social · 13/05/2026
Infectious threats don't disappear between one pandemic and the next. Public attention does. Staying informed - without noise, without alarmism - is part of being prepared. 📩 Subscribe to the AVITHRAPID newsletter: only what you need to know, when you need to know it. 👉
avithrapid.eu
Newsletter - AVITHRAPID project
Sign up Sign up and stay informed about the progress and developments of the AVITHRAPID project. You can unsubscribe at any time by clicking the link in the footer of the newsletter E-mails. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices. Newsletter Archive Newsletter 3 November 2025 Newsletter 16 June 2025 Newsletter 10 March 2025 Newsletter 4 November 2024
010
AVITHRAPID @avithrapid.bsky.social · 13/05/2026
Developing broad-spectrum antivirals against viruses with pandemic potential - and keeping aligned all the actors who make the difference when time matters most: 🔬 research centres 🏥 hospitals 🎓 universities 🏛️ policymakers 👥 citizens
110
AVITHRAPID @avithrapid.bsky.social · 13/05/2026
The confidence behind those words isn't luck. It's preparation. Years of research, shared protocols, and European networks built before the epidemic signal arrives. That's exactly what #AVITHRAPID is for 👇
100
AVITHRAPID @avithrapid.bsky.social · 13/05/2026
“We are ready - we know this virus.” 🦠 That's Emanuele Nicastri - Head of High-Intensity Infectious Diseases at INMI Spallanzani (Rome) and Principal Investigator in AVITHRAPID - speaking to Corriere della Sera today about the ongoing #Hantavirus cases.
120
AVITHRAPID @avithrapid.bsky.social · 12/05/2026
#AVITHRAPID embraces the #OneHealth vision, developing antiviral tools to ensure that when a virus jumps species, we are ready to respond.
000
AVITHRAPID @avithrapid.bsky.social · 12/05/2026
Plant Health = Human Health. 🌿🔬 Today’s #InternationalDayOfPlantHealth reminds us that human safety is tied to our ecosystems. Environmental shifts can drive zoonotic risks.
100
AVITHRAPID @avithrapid.bsky.social · 07/05/2026
#Avithrapid #Hantavirus #Orthohantavirus #GlobalHealth #PandemicPreparedness #AntiviralResearch #BioTech #HealthSecurity #MVHondius #BroadSpectrumAntivirals #Innovation #DrugDiscovery #HorizonEurope
000
AVITHRAPID @avithrapid.bsky.social · 07/05/2026
We cannot wait for the next zoonotic spillover to become the next global pandemic. The technology to stop it exists today - we are building it.
100
AVITHRAPID @avithrapid.bsky.social · 07/05/2026
✅ Accelerated drug discovery pipeline targeting viral replication mechanisms ✅ Global preparedness infrastructure capable of rapid deployment ✅ Small molecule solutions addressing logistical challenges of vaccine development and distribution
100
AVITHRAPID @avithrapid.bsky.social · 07/05/2026
• Current treatments are purely supportive - no specific antivirals available The Avithrapid exploitation platform was designed specifically to change this narrative: ✅ Broad-spectrum antiviral platform ready to respond to emerging orthohantaviruses
100
AVITHRAPID @avithrapid.bsky.social · 07/05/2026
The potential for viral spillover and sustained transmission represents a “point of no return” for global health security. Why Avithrapid is essential today: • No WHO-approved vaccine exists for any hantavirus strain • Case fatality rates reach 50% in severe cases
100